Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Merck: Phase 3 Study of Single-Dose Emend Met Primary Endpoint

June 30, 2015 11:36 am | News | Comments

Merck, known as MSD outside the United States and Canada, today announced results from a Phase 3 study investigating the safety and efficacy of single-dose EMEND (fosaprepitant dimeglumine) for Injection, Merck’s substance P/neurokinin (NK-1) receptor antagonist, in combination with other anti-vomiting medicines, for the prevention of chemotherapy-induced nausea and vomiting (CINV). Read more...


FDA's New HCT/P Draft Guidance Document: What is Minimal Manipulation in 2015?

June 30, 2015 10:04 am | by Kelly L. Lightfoot, Esq., Fuerst Ittleman David & Joseph | Articles | Comments

The first step in assessing how a HCT/P will be regulated by the FDA, and whether the resulting product will require an expensive and lengthy approval process, is determining if the HCT/P is more than minimally manipulated. Read more...


Regeneron's Retinal Vein Occlusion Treatment Receives Approval in Japan

June 30, 2015 8:39 am | News | Comments

This new indication includes macular edema secondary to branch retinal vein occlusion in addition to the previously-approved indication of macular edema secondary to central retinal vein occlusion. Read more...


Global Biosimilars Market Value Could Hit $55B by 2020

June 30, 2015 8:28 am | by Sumith Ladda, Analyst, GBI Research | Articles | Comments

The 30 percent to 50 percent reduction in biosimilar prices compared with branded biologics could lead to considerable savings in healthcare expenditure. Read more...


CHMP Recommends EU Approval for Novartis' Multiple Myeloma Treatment

June 30, 2015 8:18 am | News | Comments

Multiple myeloma is a cancer of the plasma cells, a type of white blood cell present in the bone marrow, and affects approximately 84,000 people in Europe. Read more...


New Study Verifies Accuracy of Rapid Ebola Test

June 30, 2015 8:18 am | by Tulane University | News | Comments

The study results confirm that the test can be used in the field and deliver a high level of accuracy. Read more...


Multi-Million-Dollar Deal Brings UQ Pain Drug Closer to Reality

June 30, 2015 8:18 am | by University of Queensland | News | Comments

A chronic pain treatment discovered at The University of Queensland is a step closer to clinical use. Read more...


Pharmaceutical Trade Association: Greek Medicine Supply May Be At Risk

June 30, 2015 8:17 am | by Ryan Bushey, Associate Editor | Articles | Comments

The organization is calling for the European Union to take emergency action. Read more...


Conn. Nurse Pleads Guilty to Prescribing Pain Meds for Drug-Company Kickbacks

June 29, 2015 11:56 am | by Seth Augenstein, Digital Reporter | News | Comments

A nurse admitted in federal court to prescribing pain medications in exchange for kickbacks from a drug company, according to authorities. Read more...


Lilly, Immunocore: Immunotherapy-based Clinical Trial Collaboration in Melanoma

June 29, 2015 9:48 am | News | Comments

Eli Lilly and Company and Immunocore Limited today announced that they have entered into an immunotherapy-based clinical trial collaboration to explore the utility of Immunocore's lead T cell receptor-based investigational therapeutic, IMCgp100, in combination with Lilly's galunisertib (LY2157299) and merestinib (LY2801653) for the treatment of melanoma. Read more...


Scientists Look Into Why Most Alzheimer's Patients Are Women

June 29, 2015 9:42 am | by Lauren Neergaard, AP Medical writer - Associated Press | News | Comments

Nearly two-thirds of Americans with Alzheimer's disease are women, and now some scientists are questioning the long-held assumption that it's just because they tend to live longer than men. Read more..


TSRI and Biotech Partners Find New Antibody Weapons against Marburg Virus

June 29, 2015 9:34 am | by The Scripps Research Institute | News | Comments

A new study led by scientists at The Scripps Research Institute (TSRI) identifies new immune molecules that protect against deadly Marburg virus, a relative of Ebola virus. The research provides ingredients needed to develop treatments for future Marburg outbreaks. Read more...


Turning the Tables on Cancer

June 29, 2015 9:29 am | by Shari Roan, UCLA | News | Comments

A new class of immunotherapies is enlisting the body's own immune system to fight cancer. Read more...


Blood Test IDs Pancreatic Cancer in 250 of 250 Patients

June 29, 2015 9:18 am | by Cynthia Fox, Science Editor | Articles | Comments

A new blood test identified pancreatic cancer with 100 percent accuracy in 250 of 250 patients, said a recent report in Nature. The test found pancreatic exosomes in blood via the biomarker GPC1. It distinguished early-stage cancer from late-stage cancer—with zero false positives/negatives. It predicted survival. Read more...


Novartis Acquires U.S. Biotech Firm Spinifex

June 29, 2015 8:45 am | by The Associated Press | News | Comments

Novartis didn't disclose financial details Monday of the agreement. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.